Publication:
Treatment of CD30-negative refractory mycosis fungoides with brentuximab vedotin

dc.contributor.authorConnie Zhangen_US
dc.contributor.authorManasmon Chairatchaneeboonen_US
dc.contributor.authorPaul Haunen_US
dc.contributor.authorDaniel Landsburgen_US
dc.contributor.authorEllen J. Kimen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Pennsylvaniaen_US
dc.contributor.otherUniversity of Calgaryen_US
dc.date.accessioned2019-08-28T06:34:43Z
dc.date.available2019-08-28T06:34:43Z
dc.date.issued2018-01-01en_US
dc.identifier.citationJAMA Dermatology. Vol.154, No.1 (2018), 109-110en_US
dc.identifier.doi10.1001/jamadermatol.2017.3961en_US
dc.identifier.issn21686068en_US
dc.identifier.other2-s2.0-85041125691en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/47156
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041125691&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleTreatment of CD30-negative refractory mycosis fungoides with brentuximab vedotinen_US
dc.typeLetteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041125691&origin=inwarden_US

Files

Collections